First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Circulation
Authors: Roderick Tung, Yumei Xue, Minglong Chen, Chenyang Jiang, Dalise Y. Shatz, Stephanie A. Besser, Hongde Hu, Fa-Po Chung, Shiro Nakahara, Young-Hoon Kim, Kazuhiro Satomi, Lishui Shen, Er’peng Liang, Hongtao Liao, Kai Gu, Ruhong Jiang, Jian Jiang, Yuichi Hori, Jong-Il Choi, Akiko Ueda, Yuki Komatsu, Shuichiro Kazawa, Kyoko Soejima, Shih-Ann Chen, Akihiko Nogami, Yan Yao, on behalf of PAUSE-SCD Investigators
Institutions: Sir Run Run Shaw Hospital, University of Chicago, Guangdong Provincial People's Hospital, Zhejiang University, Jiangsu Province Hospital, Sichuan University, West China Hospital of Sichuan University, National Yang Ming Chiao Tung University, Taipei Veterans General Hospital, Dokkyo Medical University Saitama Medical Center, Korea University Medical Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Fu Wai Hospital, Kyorin University Hospital, University of Tsukuba, Tokyo Medical University, Taichung Veterans General Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: monomorphic ventricular tachycardia, catheter ablation, implantable cardioverter-defibrillator, non-ischemic cardiomyopathy, arrhythmogenic cardiomyopathy, ischemic cardiomyopathy, ventricular tachycardia recurrence, ICD shocks, antitachycardia pacing, primary prevention of sudden cardiac death
Open Access status: closed
OpenAlex ID: W4225378087
